Paper1002002
Platelet-collagen interaction. The influence of native and modified collagen (Type I) on the aggregation of human platelets.
Balleisen L and 2 others. Haemostasis, 1976. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Platelet-collagen interaction. The influence of native and modified collagen (Type I) on the aggregation of human platelets. Papers, record 1002002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1002002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Platelet-collagen interaction. The influence of native and modified collagen (Type I) on the aggregation of human platelets.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagen | Major topic |
| Platelet Aggregation | Major topic |
| Amino Acid Sequence | |
| Humans | |
| Molecular Conformation |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19766712 | Antioxidants change platelet responses to various stimulating events. | Free Radic Biol Med | 2009 | https://conductscience.org/library/papers/19766712 | PubMed |
| 7534064 | Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. | Biochem J | 1995 | https://conductscience.org/library/papers/7534064 | PubMed |
| 1809397 | Distinct determinants on collagen support alpha 2 beta 1 integrin-mediated platelet adhesion and platelet activation. | Cell Regul | 1991 | https://conductscience.org/library/papers/1809397 | PubMed |
| 1252624 | [Leukocyte and erythrocyte interaction with collagen in vitro: scanning electron microscopy study]. | Blut | 1976 | https://conductscience.org/library/papers/1252624 | PubMed |
| 1186042 | Comparative investigation on the influence of human and bovine collagen types I, II and III on the aggregation of human platelets. | Klin Wochenschr | 1975 | https://conductscience.org/library/papers/1186042 | PubMed |
| 652049 | In vivo method for quantitation for anti-platelet potency of drugs. | Naunyn Schmiedebergs Arch Pharmacol | 1978 | https://conductscience.org/library/papers/652049 | PubMed |
| 395952 | Inhibition of collagen-induced platelet aggregation by antibodies to distinct types of collagens. | Biochem J | 1979 | https://conductscience.org/library/papers/395952 | PubMed |
| 288053 | Fibronectin and the multiple interaction model for platelet-collagen adhesion. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/288053 | PubMed |
| 198432 | Collagen-mediated platelet aggregation. Evidence for multivalent interactions of intermediate specificity between collagen and platelets. | J Clin Invest | 1977 | https://conductscience.org/library/papers/198432 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1002002
GET https://conductscience.org/api/papers/v1/1002002/authors